Wolff Wiese Magana LLC Biomarin Pharmaceutical Inc Transaction History

Wolff Wiese Magana LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$74.28 - $92.69 $7,576 - $9,454	-102 Closed	0 $0
Q3 2021 Oct 15, 2021	SELL	$74.77 - $85.47 $1,046 - $1,196	-14 Reduced 12.07%	102 $8,000
Q1 2021 Apr 15, 2021	SELL	$74.73 - $90.69 $8,892 - $10,792	-119 Reduced 50.64%	116 $9,000
Q4 2020 Jan 27, 2021	BUY	$72.61 - $90.2 $17,063 - $21,197	235 New	235 $21,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

Stay updated on Wolff Wiese Magana LLC with notifications on news.